Balance Sheet
Cash Flow Statement
AmortizationCapital ExpendituresCash from Investing ActivitiesCash from OperationsChange in CashExchange Rate EffectFree Cash FlowNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

Avricore Health (AVCRF) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Avricore Health (AVCRF) over the last 8 years, with Q3 2025 value amounting to -$13410.4.

  • Avricore Health's Cash from Investing Activities fell 10371.13% to -$13410.4 in Q3 2025 from the same period last year, while for Sep 2025 it was $286316.0, marking a year-over-year increase of 21812.93%. This contributed to the annual value of -$149985.3 for FY2024, which is 8066.94% up from last year.
  • Per Avricore Health's latest filing, its Cash from Investing Activities stood at -$13410.4 for Q3 2025, which was down 10371.13% from -$4204.0 recorded in Q2 2025.
  • Over the past 5 years, Avricore Health's Cash from Investing Activities peaked at $361337.4 during Q3 2024, and registered a low of -$511630.8 during Q3 2023.
  • For the 5-year period, Avricore Health's Cash from Investing Activities averaged around -$97445.8, with its median value being -$54524.3 (2021).
  • In the last 5 years, Avricore Health's Cash from Investing Activities crashed by 1828552.56% in 2023 and then skyrocketed by 17062.46% in 2024.
  • Over the past 5 years, Avricore Health's Cash from Investing Activities (Quarter) stood at -$11381.2 in 2021, then plummeted by 2743.0% to -$323567.3 in 2022, then tumbled by 58.12% to -$511630.8 in 2023, then skyrocketed by 170.62% to $361337.4 in 2024, then tumbled by 103.71% to -$13410.4 in 2025.
  • Its Cash from Investing Activities stands at -$13410.4 for Q3 2025, versus -$4204.0 for Q2 2025 and -$57407.1 for Q1 2025.